{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:49:11Z","timestamp":1747151351527,"version":"3.40.5"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Secondary hyperparathyroidism (SHPT) is common among dialysis patients, and calcimimetics are a mainstay of treatment. This study assessed whether cinacalcet use is associated with gastrointestinal bleeding in a large hemodialysis cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A linked database of clinical records and medical claims for patients receiving hemodialysis in a large dialysis organization, 2007\u20132010, was used. A nested case\u2013control study was performed among patients aged \u226518\u2009years who had received hemodialysis for \u226590\u2009days, had Medicare Parts A, B, and D coverage for \u22651\u00a0year, and had clinical evidence of SHPT (parathyroid hormone &gt;300\u2009pg\/mL). Cases were those who experienced death or hospitalization caused by gastrointestinal bleeding. Each case was matched to up to four controls. Exposure was measured by any cinacalcet use, current use, past use, cumulative exposure days, and cumulative dosage. Conditional logistic models were used to assess the association.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 48\u2009437 patients included, 2570 experienced gastrointestinal bleeding events (2498 non\u2010fatal, 72 fatal), and 2465 (2397 non\u2010fatal, 68 fatal) were matched to 9500 controls; 17.2% of cases and 15.8% of controls had cinacalcet exposure and 11.1% of both cases and controls had current use. The adjusted odds ratios (95% CI) of gastrointestinal bleeding for any use, current use, and past use of cinacalcet were 1.04 (0.91\u20131.19), 0.97 (0.83\u20131.13), and 1.22 (0.99\u20131.50), respectively, with no use as the reference.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results do not suggest an elevated risk of gastrointestinal bleeding resulting in hospitalization or death for hemodialysis patients exposed to cinacalcet.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.5337","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T06:13:08Z","timestamp":1628316788000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cinacalcet and gastrointestinal bleeding risk in patients receiving hemodialysis"],"prefix":"10.1002","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2460-9542","authenticated-orcid":false,"given":"Jiannong","family":"Liu","sequence":"first","affiliation":[{"name":"Chronic Disease Research Group Hennepin Healthcare Research Institute  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group Hennepin Healthcare Research Institute  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu\u2010Chieh","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Observational Research Amgen, Inc.  California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Wetmore","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group Hennepin Healthcare Research Institute  Minneapolis Minnesota USA"},{"name":"Division of Nephrology Hennepin Healthcare  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Bradbury","sequence":"additional","affiliation":[{"name":"Center for Observational Research Amgen, Inc.  California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Gilbertson","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group Hennepin Healthcare Research Institute  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Nieman","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group Hennepin Healthcare Research Institute  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group Hennepin Healthcare Research Institute  Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Sprafka","sequence":"additional","affiliation":[{"name":"Woodford Research Associates  Westlake Village California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Dluzniewski","sequence":"additional","affiliation":[{"name":"Center for Observational Research Amgen, Inc.  California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"United States Renal Data System.USRDS 2019 Annual Data Report. Epidemiology of Kidney Disease in the United States. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Disease. Bethesda Maryland;2019."},{"key":"e_1_2_9_3_1","first-page":"1","article-title":"Secondary hyperparathyroidism in chronic kidney disease patients; current knowledge","volume":"2","author":"Amiri M","year":"2014","journal-title":"J Parathyr Dis"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"issue":"1","key":"e_1_2_9_5_1","first-page":"i2","article-title":"The pathophysiology of secondary hyperparathyroidism and the consequences of uncontrolled mineral metabolism in chronic kidney disease: the role of COSMOS","volume":"1","author":"Cannata\u2010And\u00eda JB","year":"2008","journal-title":"NDT Plus"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001514"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.03.020"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn613"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2013.832319"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05241008"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001982"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2008.00624.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.167"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-97"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110299"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.09.010"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011070658"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213774"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2004.014472"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/106286069901400607"},{"key":"e_1_2_9_22_1","unstructured":"DOPPS.Cinacalcet use by DOPPS country and cross\u2010section.https:\/\/www.dopps.org\/annualreport\/archives\/DOPPSAR2009\/html\/vitd_cin_c_TAB2009.htm. Accessed June 29 2020."},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09550818"},{"key":"e_1_2_9_24_1","unstructured":"United States Renal Data System.USRDS 2013 Annual Data Report. Epidemiology of Kidney Disease in the United States. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Disease. Bethesda Maryland;2013."},{"key":"e_1_2_9_25_1","unstructured":"RTI International.Accuracy of coding in the hospital\u2010acquired conditions\u2013present on admission program. Final Report;2020.https:\/\/www.cms.gov\/medicare\/medicare\u2010fee\u2010for\u2010service\u2010payment\/hospitalacqcond\/downloads\/accuracy\u2010of\u2010coding\u2010final\u2010report.pdf. Accessed June 29."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.29905"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0174-6"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu551"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070064"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2007.10.011"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.06.007"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1857"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.5337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pds.5337","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.5337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T10:03:37Z","timestamp":1693217017000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.5337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1002\/pds.5337"],"URL":"https:\/\/doi.org\/10.1002\/pds.5337","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"type":"print","value":"1053-8569"},{"type":"electronic","value":"1099-1557"}],"subject":[],"published":{"date-parts":[[2021,8,19]]},"assertion":[{"value":"2020-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}